Anthera Pharmaceuticals, Inc. (OTCMKTS:ANTH – Get Free Report)’s stock price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.00. Anthera Pharmaceuticals shares last traded at $0.00, with a volume of 10,000 shares trading hands.
Anthera Pharmaceuticals Stock Down 50.0 %
Anthera Pharmaceuticals Company Profile
Anthera Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy.
Recommended Stories
- Five stocks we like better than Anthera Pharmaceuticals
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Work and Play: Investing in the Rise of Bleisure Travel
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Top Dividend Stocks to Buy Now as Bond Yields Could Lower
- Why Invest in High-Yield Dividend Stocks?
- SAP: AI Tailwinds Accelerating Enterprise Cloud Business
Receive News & Ratings for Anthera Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthera Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
